Vitamin D in the treatment of pulmonary tuberculosis
- 31 March 2007
- journal article
- review article
- Published by Elsevier BV in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 103 (3-5), 793-798
- https://doi.org/10.1016/j.jsbmb.2006.12.052
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial ResponseScience, 2006
- Tuberculosis drug development pipeline: progress and hopeThe Lancet, 2006
- Immune Regulation of 25-Hydroxyvitamin-D3-1α-Hydroxylase in Human MonocytesJournal of Bone and Mineral Research, 2006
- Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an 1α,25-dihydroxyvitamin D3–phosphoinositide 3-kinase pathwayJournal of Cell Science, 2004
- Steroid-hormone rapid actions, membrane receptors and a conformational ensemble modelNature Reviews Drug Discovery, 2004
- Stat1-Vitamin D Receptor Interactions Antagonize 1,25-Dihydroxyvitamin D Transcriptional Activity and Enhance Stat1-Mediated TranscriptionMolecular and Cellular Biology, 2002
- 1α,25-Dihydroxyvitamin D3-induced Monocyte Antimycobacterial Activity Is Regulated by Phosphatidylinositol 3-Kinase and Mediated by the NADPH-dependent Phagocyte OxidaseJournal of Biological Chemistry, 2001
- CALCIFEROL, STREPTOMYCIN, AND PARA-AMINOSALICYLIC ACID IN PULMONARY TUBERCULOSISThe Lancet, 1951
- TREATMENT OF LUPUS VULGARIS WITH CALCIFEROLThe Lancet, 1946
- Cod-liver Oil in PhthisisBMJ, 1849